{"id":19696,"date":"2022-04-13T11:40:26","date_gmt":"2022-04-13T09:40:26","guid":{"rendered":"https:\/\/www.izb-online.de\/?p=19696"},"modified":"2022-04-13T11:55:44","modified_gmt":"2022-04-13T09:55:44","slug":"neurology-long-term-benzodiazepine-use-attacks-synapses","status":"publish","type":"post","link":"https:\/\/www.izb-online.de\/en\/izb-biotech-news\/neurology-long-term-benzodiazepine-use-attacks-synapses\/","title":{"rendered":"Neurology: Long-term benzodiazepine use attacks synapses"},"content":{"rendered":"<div class=\"wpb-content-wrapper\"><p>[vc_row el_class=&#8221;gco-magazine-container&#8221;][vc_column el_class=&#8221;bildspalte&#8221;][vc_row_inner][vc_column_inner offset=&#8221;vc_col-lg-12 vc_col-md-12&#8243;][vc_column_text el_class=&#8221;gco-magazine&#8211;title&#8221;]<\/p>\n<h1>Neurology: Long-term benzodiazepine use attacks synapses<\/h1>\n<p>[\/vc_column_text][vc_column_text el_class=&#8221;gco-magazine-lead&#8221;]LMU and DZNE scientists show in animal models that benzodiazepines lead to the loss of neural connections in the brain.[\/vc_column_text][vc_column_text el_class=&#8221;gco-magazine&#8211;post-date&#8221;]April 2022[\/vc_column_text][\/vc_column_inner][\/vc_row_inner][vc_row_inner][vc_column_inner][vc_single_image image=&#8221;19732&#8243; img_size=&#8221;full&#8221;][vc_column_text el_class=&#8221;gco-magazine-copyright&#8221;]\u00a9 E. Fessler, Jae Lab[\/vc_column_text][vc_column_text el_class=&#8221;gco-magazine-picture-discription&#8221;]DELE1 (green) is constantly imported into mitochondria (magenta) and degraded there. Errors in this process warn the cell nucleus (blue).[\/vc_column_text][\/vc_column_inner][\/vc_row_inner][vc_row_inner el_class=&#8221;gco-magazine&#8211;quote&#8221; css=&#8221;.vc_custom_1611310713611{margin-top: 33px !important;}&#8221;][vc_column_inner][vc_column_text]<\/p>\n<h6 style=\"text-align: center;\">&#8220;While it was known that microglia play an important role in the elimination of synapses both during brain development and in neurodegenerative diseases. What was very surprising to us, however, was that drugs as well-studied as benzodiazepines affect this process.&#8221;<\/h6>\n<p style=\"text-align: center;\">Yuan Shi and Mochen Cui<br \/>\nco-authors of the study<\/p>\n<p>[\/vc_column_text][\/vc_column_inner][\/vc_row_inner][vc_row_inner el_class=&#8221;gco-magazine-container&#8211;copy&#8221; css=&#8221;.vc_custom_1591795890737{margin-top: 21px !important;}&#8221;][vc_column_inner][vc_column_text]Especially in elderly people, long-term use of the widely used tranquilizers can lead to cognitive impairment. The study provides the first mechanistic explanation and may influence future treatment of people at risk for dementia, according to the authors. Benzodiazepines may lead to cognitive impairment<\/p>\n<p><strong>Benzodiazepines may lead to cognitive impairment<br \/>\n<\/strong>Benzodiazepines are effective and widely used medications to treat anxiety and sleep disorders. While short-term treatments are considered safe, their long-term use can lead to physical dependence and, especially in the elderly, cognitive impairment. The way in which benzodiazepines trigger these changes was previously unknown. Researchers led by Prof. Jochen Herms and Dr. Mario Dorostkar from the Center for Neuropathology and Prion Research at LMU and the German Center for Neurodegenerative Diseases have now been able to demonstrate in an animal model that the drug leads to the loss of nerve connections in the brain.<\/p>\n<p><strong>Synapses are degraded and recycled by activated microglia<br \/>\n<\/strong>Immune cells of the brain, so-called microglia, play a central role in this process. Benzodiazepines bind to a specific protein &#8211; the translocator protein (TSPO) &#8211; on the surface of cell organelles of the microglia. This binding activates the microglia, which then break down and recycle synapses, connections between neurons. Experiments by the scientists showed that synapse loss led to cognitive impairment in mice that had received a sleep-inducing dose of the benzodiazepine diazepam daily for several weeks.<\/p>\n<p>&#8220;While it was known that microglia play an important role in the elimination of synapses both during brain development and in neurodegenerative diseases,&#8221; said Drs. Yuan Shi and Mochen Cui, co-authors of the study. &#8220;But what was very surprising to us was that drugs as well-studied as benzodiazepines affect this process.&#8221; After stopping diazepam, the effect lasted even longer, but was ultimately reversible.<\/p>\n<p><strong>New insights for treatment of sleep disorders and anxiety<br \/>\n<\/strong>According to the researchers, the study could have implications for the treatment of sleep disorders and anxiety in people at risk for dementia. &#8220;Drugs known to have no affinity for TSPO should be preferred when possible,&#8221; the authors said.<\/p>\n<p><strong>Contact:<br \/>\nDr. Mario Dorostkar<\/strong><br \/>\nZentrum f\u00fcr Neuropathologie<br \/>\nT: +49 89 2180 78065<br \/>\nMario.Dorostkar@med.uni-muenchen.de<br \/>\n<a href=\"https:\/\/www.neuropathologie.med.uni-muenchen.de\/mitarbeiter\/institutsleitung\/dorostkar_mario\/index.html\"><strong>https:\/\/www.neuropathologie.med.uni-muenchen.de\/mitarbeiter\/institutsleitung\/dorostkar_mario\/index.html<\/strong><\/a><\/p>\n<p><strong>Prof. Dr. Jochen Herms<\/strong><br \/>\nDeutsches Zentrum f\u00fcr Neurodegenerative Erkrankungen (DZNE) und<br \/>\nMunich Cluster for Systems Neurology (SyNergy)<br \/>\nT: +49 89 4400 46427<br \/>\nJochen.Herms@med.uni-muenchen.de<br \/>\n<a href=\"https:\/\/www.dzne.de\/forschung\/forschungsbereiche\/grundlagenforschung\/forschungsgruppen\/herms\/forschungsschwerpunkte\/\"><strong>https:\/\/www.dzne.de\/forschung\/forschungsbereiche\/grundlagenforschung\/forschungsgruppen\/herms\/forschungsschwerpunkte\/<\/strong><\/a>[\/vc_column_text][vc_column_text css=&#8221;.vc_custom_1583761043671{background-color: #1e73be !important;}&#8221; el_class=&#8221;redaktionell&#8221;][\/vc_column_text][\/vc_column_inner][\/vc_row_inner][\/vc_column][\/vc_row]<\/p>\n<\/div>","protected":false},"excerpt":{"rendered":"<p><span class=\"gco-utils-excerpt\" data-debug-trim-excerpt=\"119\"><span class=\"gco-utils-excerpt__part-xs\">LMU and DZNE scientists show in animal models that benzodiazepines lead to the loss of<\/span><span class=\"gco-utils-excerpt__part-xl\"> neural connections in the<\/span><\/span><\/p>\n","protected":false},"author":8,"featured_media":19734,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":"","_links_to":"","_links_to_target":""},"categories":[1540,1539],"tags":[],"class_list":["post-19696","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-campus","category-izb-biotech-news"],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v28.1 (Yoast SEO v28.1) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>Neurology: Long-term benzodiazepine use attacks synapses - Innovations- und Gr\u00fcnderzentrum Biotechnologie IZB<\/title>\n<meta name=\"description\" content=\"LMU and DZNE scientists show in animal models that benzodiazepines lead to the loss of neural connections in the brain.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.izb-online.de\/en\/izb-biotech-news\/neurology-long-term-benzodiazepine-use-attacks-synapses\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Neurology: Long-term benzodiazepine use attacks synapses\" \/>\n<meta property=\"og:description\" content=\"LMU and DZNE scientists show in animal models that benzodiazepines lead to the loss of neural connections in the brain.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.izb-online.de\/en\/izb-biotech-news\/neurology-long-term-benzodiazepine-use-attacks-synapses\/\" \/>\n<meta property=\"og:site_name\" content=\"Innovations- und Gr\u00fcnderzentrum Biotechnologie IZB\" \/>\n<meta property=\"article:published_time\" content=\"2022-04-13T09:40:26+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2022-04-13T09:55:44+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.izb-online.de\/wp-content\/uploads\/2022\/04\/lmu-april-post.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"600\" \/>\n\t<meta property=\"og:image:height\" content=\"383\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"martin Reznicek\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"martin Reznicek\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"NewsArticle\",\"@id\":\"https:\\\/\\\/www.izb-online.de\\\/en\\\/izb-biotech-news\\\/neurology-long-term-benzodiazepine-use-attacks-synapses\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.izb-online.de\\\/en\\\/izb-biotech-news\\\/neurology-long-term-benzodiazepine-use-attacks-synapses\\\/\"},\"author\":{\"name\":\"martin Reznicek\",\"@id\":\"https:\\\/\\\/www.izb-online.de\\\/en\\\/#\\\/schema\\\/person\\\/d8c3fdae36f92a8c67f39af096dd9437\"},\"headline\":\"Neurology: Long-term benzodiazepine use attacks synapses\",\"datePublished\":\"2022-04-13T09:40:26+00:00\",\"dateModified\":\"2022-04-13T09:55:44+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.izb-online.de\\\/en\\\/izb-biotech-news\\\/neurology-long-term-benzodiazepine-use-attacks-synapses\\\/\"},\"wordCount\":673,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\\\/\\\/www.izb-online.de\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/www.izb-online.de\\\/en\\\/izb-biotech-news\\\/neurology-long-term-benzodiazepine-use-attacks-synapses\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.izb-online.de\\\/wp-content\\\/uploads\\\/2022\\\/04\\\/lmu-april-post.jpg\",\"articleSection\":[\"Campus\",\"IZB Biotech News\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/www.izb-online.de\\\/en\\\/izb-biotech-news\\\/neurology-long-term-benzodiazepine-use-attacks-synapses\\\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.izb-online.de\\\/en\\\/izb-biotech-news\\\/neurology-long-term-benzodiazepine-use-attacks-synapses\\\/\",\"url\":\"https:\\\/\\\/www.izb-online.de\\\/en\\\/izb-biotech-news\\\/neurology-long-term-benzodiazepine-use-attacks-synapses\\\/\",\"name\":\"Neurology: Long-term benzodiazepine use attacks synapses - Innovations- und Gr\u00fcnderzentrum Biotechnologie IZB\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.izb-online.de\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.izb-online.de\\\/en\\\/izb-biotech-news\\\/neurology-long-term-benzodiazepine-use-attacks-synapses\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.izb-online.de\\\/en\\\/izb-biotech-news\\\/neurology-long-term-benzodiazepine-use-attacks-synapses\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.izb-online.de\\\/wp-content\\\/uploads\\\/2022\\\/04\\\/lmu-april-post.jpg\",\"datePublished\":\"2022-04-13T09:40:26+00:00\",\"dateModified\":\"2022-04-13T09:55:44+00:00\",\"description\":\"LMU and DZNE scientists show in animal models that benzodiazepines lead to the loss of neural connections in the brain.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.izb-online.de\\\/en\\\/izb-biotech-news\\\/neurology-long-term-benzodiazepine-use-attacks-synapses\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.izb-online.de\\\/en\\\/izb-biotech-news\\\/neurology-long-term-benzodiazepine-use-attacks-synapses\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.izb-online.de\\\/en\\\/izb-biotech-news\\\/neurology-long-term-benzodiazepine-use-attacks-synapses\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.izb-online.de\\\/wp-content\\\/uploads\\\/2022\\\/04\\\/lmu-april-post.jpg\",\"contentUrl\":\"https:\\\/\\\/www.izb-online.de\\\/wp-content\\\/uploads\\\/2022\\\/04\\\/lmu-april-post.jpg\",\"width\":600,\"height\":383},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.izb-online.de\\\/en\\\/izb-biotech-news\\\/neurology-long-term-benzodiazepine-use-attacks-synapses\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.izb-online.de\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"IZB Biotech News\",\"item\":\"https:\\\/\\\/www.izb-online.de\\\/en\\\/izb-biotech-news\\\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"Neurology: Long-term benzodiazepine use attacks synapses\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.izb-online.de\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/www.izb-online.de\\\/en\\\/\",\"name\":\"Innovations- und Gr\u00fcnderzentrum Biotechnologie IZB\",\"description\":\"Innovations- und Gr\u00fcnderzentrum Biotechnologie\",\"publisher\":{\"@id\":\"https:\\\/\\\/www.izb-online.de\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.izb-online.de\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/www.izb-online.de\\\/en\\\/#organization\",\"name\":\"F\u00f6rdergesellschaft IZB mbH\",\"url\":\"https:\\\/\\\/www.izb-online.de\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.izb-online.de\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/www.izb-online.de\\\/wp-content\\\/uploads\\\/2020\\\/06\\\/izb-logo.svg\",\"contentUrl\":\"https:\\\/\\\/www.izb-online.de\\\/wp-content\\\/uploads\\\/2020\\\/06\\\/izb-logo.svg\",\"width\":1,\"height\":1,\"caption\":\"F\u00f6rdergesellschaft IZB mbH\"},\"image\":{\"@id\":\"https:\\\/\\\/www.izb-online.de\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.izb-online.de\\\/en\\\/#\\\/schema\\\/person\\\/d8c3fdae36f92a8c67f39af096dd9437\",\"name\":\"martin Reznicek\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Neurology: Long-term benzodiazepine use attacks synapses - Innovations- und Gr\u00fcnderzentrum Biotechnologie IZB","description":"LMU and DZNE scientists show in animal models that benzodiazepines lead to the loss of neural connections in the brain.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.izb-online.de\/en\/izb-biotech-news\/neurology-long-term-benzodiazepine-use-attacks-synapses\/","og_locale":"en_US","og_type":"article","og_title":"Neurology: Long-term benzodiazepine use attacks synapses","og_description":"LMU and DZNE scientists show in animal models that benzodiazepines lead to the loss of neural connections in the brain.","og_url":"https:\/\/www.izb-online.de\/en\/izb-biotech-news\/neurology-long-term-benzodiazepine-use-attacks-synapses\/","og_site_name":"Innovations- und Gr\u00fcnderzentrum Biotechnologie IZB","article_published_time":"2022-04-13T09:40:26+00:00","article_modified_time":"2022-04-13T09:55:44+00:00","og_image":[{"width":600,"height":383,"url":"https:\/\/www.izb-online.de\/wp-content\/uploads\/2022\/04\/lmu-april-post.jpg","type":"image\/jpeg"}],"author":"martin Reznicek","twitter_card":"summary_large_image","twitter_misc":{"Written by":"martin Reznicek","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"NewsArticle","@id":"https:\/\/www.izb-online.de\/en\/izb-biotech-news\/neurology-long-term-benzodiazepine-use-attacks-synapses\/#article","isPartOf":{"@id":"https:\/\/www.izb-online.de\/en\/izb-biotech-news\/neurology-long-term-benzodiazepine-use-attacks-synapses\/"},"author":{"name":"martin Reznicek","@id":"https:\/\/www.izb-online.de\/en\/#\/schema\/person\/d8c3fdae36f92a8c67f39af096dd9437"},"headline":"Neurology: Long-term benzodiazepine use attacks synapses","datePublished":"2022-04-13T09:40:26+00:00","dateModified":"2022-04-13T09:55:44+00:00","mainEntityOfPage":{"@id":"https:\/\/www.izb-online.de\/en\/izb-biotech-news\/neurology-long-term-benzodiazepine-use-attacks-synapses\/"},"wordCount":673,"commentCount":0,"publisher":{"@id":"https:\/\/www.izb-online.de\/en\/#organization"},"image":{"@id":"https:\/\/www.izb-online.de\/en\/izb-biotech-news\/neurology-long-term-benzodiazepine-use-attacks-synapses\/#primaryimage"},"thumbnailUrl":"https:\/\/www.izb-online.de\/wp-content\/uploads\/2022\/04\/lmu-april-post.jpg","articleSection":["Campus","IZB Biotech News"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/www.izb-online.de\/en\/izb-biotech-news\/neurology-long-term-benzodiazepine-use-attacks-synapses\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/www.izb-online.de\/en\/izb-biotech-news\/neurology-long-term-benzodiazepine-use-attacks-synapses\/","url":"https:\/\/www.izb-online.de\/en\/izb-biotech-news\/neurology-long-term-benzodiazepine-use-attacks-synapses\/","name":"Neurology: Long-term benzodiazepine use attacks synapses - Innovations- und Gr\u00fcnderzentrum Biotechnologie IZB","isPartOf":{"@id":"https:\/\/www.izb-online.de\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.izb-online.de\/en\/izb-biotech-news\/neurology-long-term-benzodiazepine-use-attacks-synapses\/#primaryimage"},"image":{"@id":"https:\/\/www.izb-online.de\/en\/izb-biotech-news\/neurology-long-term-benzodiazepine-use-attacks-synapses\/#primaryimage"},"thumbnailUrl":"https:\/\/www.izb-online.de\/wp-content\/uploads\/2022\/04\/lmu-april-post.jpg","datePublished":"2022-04-13T09:40:26+00:00","dateModified":"2022-04-13T09:55:44+00:00","description":"LMU and DZNE scientists show in animal models that benzodiazepines lead to the loss of neural connections in the brain.","breadcrumb":{"@id":"https:\/\/www.izb-online.de\/en\/izb-biotech-news\/neurology-long-term-benzodiazepine-use-attacks-synapses\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.izb-online.de\/en\/izb-biotech-news\/neurology-long-term-benzodiazepine-use-attacks-synapses\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.izb-online.de\/en\/izb-biotech-news\/neurology-long-term-benzodiazepine-use-attacks-synapses\/#primaryimage","url":"https:\/\/www.izb-online.de\/wp-content\/uploads\/2022\/04\/lmu-april-post.jpg","contentUrl":"https:\/\/www.izb-online.de\/wp-content\/uploads\/2022\/04\/lmu-april-post.jpg","width":600,"height":383},{"@type":"BreadcrumbList","@id":"https:\/\/www.izb-online.de\/en\/izb-biotech-news\/neurology-long-term-benzodiazepine-use-attacks-synapses\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.izb-online.de\/en\/"},{"@type":"ListItem","position":2,"name":"IZB Biotech News","item":"https:\/\/www.izb-online.de\/en\/izb-biotech-news\/"},{"@type":"ListItem","position":3,"name":"Neurology: Long-term benzodiazepine use attacks synapses"}]},{"@type":"WebSite","@id":"https:\/\/www.izb-online.de\/en\/#website","url":"https:\/\/www.izb-online.de\/en\/","name":"Innovations- und Gr\u00fcnderzentrum Biotechnologie IZB","description":"Innovations- und Gr\u00fcnderzentrum Biotechnologie","publisher":{"@id":"https:\/\/www.izb-online.de\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.izb-online.de\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/www.izb-online.de\/en\/#organization","name":"F\u00f6rdergesellschaft IZB mbH","url":"https:\/\/www.izb-online.de\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.izb-online.de\/en\/#\/schema\/logo\/image\/","url":"https:\/\/www.izb-online.de\/wp-content\/uploads\/2020\/06\/izb-logo.svg","contentUrl":"https:\/\/www.izb-online.de\/wp-content\/uploads\/2020\/06\/izb-logo.svg","width":1,"height":1,"caption":"F\u00f6rdergesellschaft IZB mbH"},"image":{"@id":"https:\/\/www.izb-online.de\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/www.izb-online.de\/en\/#\/schema\/person\/d8c3fdae36f92a8c67f39af096dd9437","name":"martin Reznicek"}]}},"_links":{"self":[{"href":"https:\/\/www.izb-online.de\/en\/wp-json\/wp\/v2\/posts\/19696","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.izb-online.de\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.izb-online.de\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.izb-online.de\/en\/wp-json\/wp\/v2\/users\/8"}],"replies":[{"embeddable":true,"href":"https:\/\/www.izb-online.de\/en\/wp-json\/wp\/v2\/comments?post=19696"}],"version-history":[{"count":7,"href":"https:\/\/www.izb-online.de\/en\/wp-json\/wp\/v2\/posts\/19696\/revisions"}],"predecessor-version":[{"id":19740,"href":"https:\/\/www.izb-online.de\/en\/wp-json\/wp\/v2\/posts\/19696\/revisions\/19740"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.izb-online.de\/en\/wp-json\/wp\/v2\/media\/19734"}],"wp:attachment":[{"href":"https:\/\/www.izb-online.de\/en\/wp-json\/wp\/v2\/media?parent=19696"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.izb-online.de\/en\/wp-json\/wp\/v2\/categories?post=19696"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.izb-online.de\/en\/wp-json\/wp\/v2\/tags?post=19696"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}